24 December 2024
Pod Point Group Holdings PLC
("Pod Point" or "the Company")
Directorate Change
Pod Point, one of the UK's market leading providers of Electric Vehicle ("EV") charging solutions in the UK, today announces a Directorate change.
Philippe Commaret, an EDF nominated Non-Executive Director ("NED") has notified the Board of his intention to step down as a Director with effect from 10 January 2025, due to his other business commitments.
The Board is aware that EDF Energy Customers Limited does not currently intend to nominate another Director in place of Philippe, although it remains able to do so under the terms of the Relationship Agreement.
Andy Palmer, Pod Point Chair, "On behalf of the Board and the Company, I would like to thank Philippe for the significant contribution he has made to the Company since IPO and wish him well for the future. The Group is working hard to deliver against our strategic plan and financial targets, and the Board remains confident in the Group's future. EDF remains a very supportive shareholder and strategic partner of the Group and still has an appointed NED on the Board."
Enquiries
| Teneo | +44 207 353 4200
|
| Matt Low, Arthur Rogers | |
About Pod Point
Pod Point was founded in 2009. Driven by a belief that driving shouldn't cost the earth, Pod Point is building the infrastructure needed to enable the mass adoption of electric vehicles and to make living with an EV easy and affordable for everyone. As at 30 June 2024, the company has an installed base of more than 250,000 communicating charge points on its network in the UK and is an official charge point supplier for major car brands.
Pod Point works with a broad range of organisations and customers to offer home and commercial charging solutions.
Pod Point is admitted to trading on the London Stock Exchange under the ticker symbol "PODP."
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.